Literature DB >> 26676054

Identification of crucial genes related to postmenopausal osteoporosis using gene expression profiling.

Min Ma1, Xiaofei Chen2, Liangyu Lu1, Feng Yuan1, Wen Zeng1, Shulin Luo1, Feng Yin3, Junfeng Cai4.   

Abstract

BACKGROUND: Postmenopausal osteoporosis is a common bone disease and characterized by low bone mineral density. AIM: This study aimed to reveal key genes associated with postmenopausal osteoporosis (PMO), and provide a theoretical basis for subsequent experiments.
METHODS: The dataset GSE7429 was obtained from Gene Expression Omnibus. A total of 20 B cell samples (ten ones, respectively from postmenopausal women with low or high bone mineral density (BMD) were included in this dataset. Following screening of differentially expressed genes (DEGs), coexpression analysis of all genes was performed, and key genes in the coexpression network were screened using the random walk algorithm. Afterwards, functional and pathway analyses were conducted. Additionally, protein-protein interactions (PPIs) between DEGs and key genes were analyzed.
RESULTS: A set of 308 DEGs (170 up-regulated ones and 138 down-regulated ones) between low BMD and high BMD samples were identified, and 101 key genes in the coexpression network were screened out. In the coexpression network, some genes had a higher score and degree, such as CSTA. The key genes in the coexpression network were mainly enriched in GO terms of the defense response (e.g., SERPINA1 and CST3), immune response (e.g., IL32 and CLEC7A); while, the DEGs were mainly enriched in structural constituent of cytoskeleton (e.g., CYLC2 and TUBA1B) and membrane-enclosed lumen (e.g., CCNE1 and INTS5). In the PPI network, CCNE1 interacted with REL; and TUBA1B interacted with ESR1.
CONCLUSIONS: A series of interactions, such as CSTA/TYROBP, CCNE1/REL and TUBA1B/ESR1 might play pivotal roles in the occurrence and development of PMO.

Entities:  

Keywords:  Coexpression; Differentially expressed gene; Network; Postmenopausal osteoporosis; Protein–protein interaction

Mesh:

Year:  2015        PMID: 26676054     DOI: 10.1007/s40520-015-0509-y

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  10 in total

Review 1.  P4 medicine and osteoporosis: a systematic review.

Authors:  Klemen Kodrič; Klemen Čamernik; Darko Černe; Radko Komadina; Janja Marc
Journal:  Wien Klin Wochenschr       Date:  2016-11-21       Impact factor: 1.704

2.  Network based subcellular proteomics in monocyte membrane revealed novel candidate genes involved in osteoporosis.

Authors:  Y Zeng; L Zhang; W Zhu; H He; H Sheng; Q Tian; F-Y Deng; L-S Zhang; H-G Hu; H-W Deng
Journal:  Osteoporos Int       Date:  2017-07-24       Impact factor: 4.507

3.  GYY4137 stimulates osteoblastic cell proliferation and differentiation via an ERK1/2-dependent anti-oxidant mechanism.

Authors:  Meng Lv; Yang Liu; Ting-Hui Xiao; Wei Jiang; Bo-Wen Lin; Xiao-Ming Zhang; Yi-Miao Lin; Zhong-Shi Xu
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

4.  Whole exome sequencing reveals potentially pathogenic variants in a small subset of premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; Joseph Hostyk; Evan H Baugh; Christie M Buchovecky; Vimla S Aggarwal; Robert R Recker; Joan M Lappe; David W Dempster; Hua Zhou; Mafo Kamanda-Kosseh; Mariana Bucovsky; Julie Stubby; David B Goldstein; Elizabeth Shane
Journal:  Bone       Date:  2021-11-04       Impact factor: 4.398

5.  Genetic architecture of bone quality variation in layer chickens revealed by a genome-wide association study.

Authors:  Jun Guo; Congjiao Sun; Liang Qu; Manman Shen; Taocun Dou; Meng Ma; Kehua Wang; Ning Yang
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

6.  Identification of aberrantly expressed long non-coding RNAs in postmenopausal osteoporosis.

Authors:  Qi Fei; Xiaodong Bai; Jisheng Lin; Hai Meng; Yong Yang; Ai Guo
Journal:  Int J Mol Med       Date:  2018-03-19       Impact factor: 4.101

7.  MiR-16-5p regulates postmenopausal osteoporosis by directly targeting VEGFA.

Authors:  Tao Yu; Xiaomeng You; Haichao Zhou; Wenbao He; Zihua Li; Bing Li; Jiang Xia; Hui Zhu; Youguang Zhao; Guangrong Yu; Yuan Xiong; Yunfeng Yang
Journal:  Aging (Albany NY)       Date:  2020-05-19       Impact factor: 5.682

8.  Identification of gene biomarkers in patients with postmenopausal osteoporosis.

Authors:  Chenggang Yang; Jing Ren; Bangling Li; Chuandi Jin; Cui Ma; Cheng Cheng; Yaolan Sun; Xiaofeng Shi
Journal:  Mol Med Rep       Date:  2018-12-12       Impact factor: 2.952

9.  LncRNA SNHG1 was down-regulated after menopause and participates in postmenopausal osteoporosis.

Authors:  Shuaihao Huang; Xiaowen Zhu; Dan Xiao; Jianxiong Zhuang; Guoyan Liang; Changxiang Liang; Xiaoqing Zheng; Yuhong Ke; Yunbing Chang
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

10.  Development and validation of a gene signature predicting the risk of postmenopausal osteoporosis.

Authors:  Wei Yuan; Maowei Yang; Yue Zhu
Journal:  Bone Joint Res       Date:  2022-08       Impact factor: 4.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.